Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1979 Jan;76(1):518–520. doi: 10.1073/pnas.76.1.518

Prolyl-leucyl-glycinamide, cyclo(leucylglycine), and derivatives block development of physical dependence on morphine in mice.

R Walter, R F Ritzmann, H N Bhargava, L B Flexner
PMCID: PMC382973  PMID: 284370

Abstract

Pro-Leu-Gly-NH2 (MIF) and several structural analogues, all injected in 50-microgram doses daily in mice receiving morphine chronically, were found to prevent development of physical dependence as measured by changes in body temperature associated with naloxone-induced withdrawal. Dose-response studies, using again a protocol of daily injections of peptide at 50, 5, 0.5, 0.05, 0.005 microgram per mouse revealed MIF and cyclo(Leu-Gly) to be the most potent peptides and to be effective in blocking physical dependence to morphine at a dose as low as 0.5 and 0.05 microgram per mouse, respectively. The benzyloxycarbonyl derivative of MIF, Pro-Leu, and Pro- -Leu exhibited significant activities down to a dose of 5 microgram of peptide per mouse.

Full text

PDF
518

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhargava H. N., Afifi A. H., Way E. L. Effect of chemical sympathectomy on morphine antinociception and tolerance development in the rat. Biochem Pharmacol. 1973 Nov 1;22(21):2769–2772. doi: 10.1016/0006-2952(73)90139-1. [DOI] [PubMed] [Google Scholar]
  2. Bhargava H. N., Matwyshyn G. A. Brain serotonin turnover and morphine tolerance-dependence induced by multiple injections in the rat. Eur J Pharmacol. 1977 Jul 1;44(1):25–33. doi: 10.1016/0014-2999(77)90112-1. [DOI] [PubMed] [Google Scholar]
  3. Bhargava H. N. Rapid induction and quantitation of morphine dependence in the rat by pellet implantation. Psychopharmacology (Berl) 1977 Mar 23;52(1):55–62. doi: 10.1007/BF00426600. [DOI] [PubMed] [Google Scholar]
  4. Bhargava H. N. Time course of the effects of naturally occurring cannabinoids on morphine abstinence syndrome. Pharmacol Biochem Behav. 1978 Jan;8(1):7–11. doi: 10.1016/0091-3057(78)90115-6. [DOI] [PubMed] [Google Scholar]
  5. Bhargava H. N., Way E. L. Effect of 1-phenyl-3-(2-thiazolyl)-2-thiourea, a dopamine beta-hydroxylase inhibitor on morphine analgesia, tolerance and physical dependence. J Pharmacol Exp Ther. 1974 Jul;190(1):165–175. [PubMed] [Google Scholar]
  6. Celis M. E., Taleisnik S., Walter R. Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte-stimulating hormone. Proc Natl Acad Sci U S A. 1971 Jul;68(7):1428–1433. doi: 10.1073/pnas.68.7.1428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Flexner J. B., Flexner L. B., Hoffman P. L., Walter R. Dose-response relationships in attenuation of puromycin-induced amnesia by neurohypophyseal peptides. Brain Res. 1977 Sep 23;134(1):139–144. doi: 10.1016/0006-8993(77)90931-3. [DOI] [PubMed] [Google Scholar]
  8. Flexner J. B., Flexner L. B., Walter R., Hoffman P. L. ADH and related peptides: effect of pre- or posttraining treatment on puromycin amnesia. Pharmacol Biochem Behav. 1978 Jan;8(1):93–95. doi: 10.1016/0091-3057(78)90129-6. [DOI] [PubMed] [Google Scholar]
  9. Hoffman P. L., Walter R., Bulat M. An enzymatically stable peptide with activity in the central nervous system: its penetration through the blood-CSF barrier. Brain Res. 1977 Feb 11;122(1):87–94. doi: 10.1016/0006-8993(77)90664-3. [DOI] [PubMed] [Google Scholar]
  10. Nair R. M., Kastin A. J., Schally A. V. Isolation and structure of hypothalamic MSH release-inhibition hormone. Biochem Biophys Res Commun. 1971 Jun 18;43(6):1376–1381. doi: 10.1016/s0006-291x(71)80026-8. [DOI] [PubMed] [Google Scholar]
  11. Walter R., Hoffman P. L., Flexner J. B., Flexner L. B. Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia. Proc Natl Acad Sci U S A. 1975 Oct;72(10):4180–4184. doi: 10.1073/pnas.72.10.4180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Walter R., Ritzmann R. F., Bhargava H. N., Rainbow T. C., Flexner L. B., Krivoy W. A. Inhibition by Z-Pro-D-Leu of development of tolerance to and physical dependence on morphine in mice. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4573–4576. doi: 10.1073/pnas.75.9.4573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. van Ree J. M., de Wied D. Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependence. Life Sci. 1976 Nov 1;19(9):1331–1339. doi: 10.1016/0024-3205(76)90430-6. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES